Found: 11
Select item for more details and to access through your institution.
Neuro-otological and peripheral nerve involvement in Fabry disease.
- Published in:
- Audiology Research, 2017, v. 7, n. 2, p. 42, doi. 10.4081/audiores.2017.176
- By:
- Publication type:
- Article
AGALSIDASE ALFA LONG-TERM EFFECT ON LEFT VENTRICULAR HYPERTROPHY IN FABRY DISEASE.
- Published in:
- Medicina (Buenos Aires), 2024, v. 84, n. 3, p. 516
- By:
- Publication type:
- Article
MAJOR CARDIOVASCULAR ADVERSE EVENTS IN FABRY DISEASE PATIENTS RECEIVING AGALSIDASE ALFA.
- Published in:
- Medicina (Buenos Aires), 2021, v. 81, n. 2, p. 173
- By:
- Publication type:
- Article
GUÍA PARA EL DIAGNÓSTICO, SEGUIMIENTO Y TRATAMIENTO DE LA ENFERMEDAD DE FABRY.
- Published in:
- Medicina (Buenos Aires), 2013, v. 73, n. 5, p. 482
- By:
- Publication type:
- Article
HOME INFUSION PROGRAM FOR FABRY DISEASE: EXPERIENCE WITH AGALSIDASE ALFA IN ARGENTINA.
- Published in:
- Medicina (Buenos Aires), 2013, v. 73, n. 1, p. 31
- By:
- Publication type:
- Article
Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 7, p. 584, doi. 10.1002/ajh.24012
- By:
- Publication type:
- Article
Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double-blind, multinational, Phase 3 study.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 166, doi. 10.1002/ajh.23381
- By:
- Publication type:
- Article
Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 179, doi. 10.1002/ajh.23382
- By:
- Publication type:
- Article
Apical Left Ventricular Hypertrophy and Mid-Ventricular Obstruction in Fabry Disease.
- Published in:
- Echocardiography, 2015, v. 32, n. 5, p. 860, doi. 10.1111/echo.12900
- By:
- Publication type:
- Article
Two-Dimensional Speckle Tracking Echocardiography for Early Detection of Myocardial Damage in Young Patients with Fabry Disease.
- Published in:
- Echocardiography, 2013, v. 30, n. 9, p. 1069, doi. 10.1111/echo.12216
- By:
- Publication type:
- Article
MAJOR CARDIOVASCULAR ADVERSE EVENTS IN FABRY DISEASE PATIENTS RECEIVING AGALSIDASE ALFA.
- Published in:
- Revista Medicina, 2021, v. 81, n. 2, p. 173
- By:
- Publication type:
- Article